Drug resistance and new therapies in colorectal cancer

World Journal of Gastroenterology : WJG
Kevin Van der JeughtGuang Ji

Abstract

Colorectal cancer (CRC) is often diagnosed at an advanced stage when tumor cell dissemination has taken place. Chemo- and targeted therapies provide only a limited increase of overall survival for these patients. The major reason for clinical outcome finds its origin in therapy resistance. Escape mechanisms to both chemo- and targeted therapy remain the main culprits. Here, we evaluate major resistant mechanisms and elaborate on potential new therapies. Amongst promising therapies is α-amanitin antibody-drug conjugate targeting hemizygous p53 loss. It becomes clear that a dynamic interaction with the tumor microenvironment exists and that this dictates therapeutic outcome. In addition, CRC displays a limited response to checkpoint inhibitors, as only a minority of patients with microsatellite instable high tumors is susceptible. In this review, we highlight new developments with clinical potentials to augment responses to checkpoint inhibitors.

References

Jan 1, 1977·Annual Review of Microbiology·D C Savage
Oct 23, 1970·Science·T J LindellW J Rutter
Mar 1, 1995·Nature Genetics·P BranchP Karran
Sep 23, 2000·Nature·G D YancopoulosJ Holash
Nov 25, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·F OkadaM Hosokawa
Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·I SaeterdalG Gaudernack
May 20, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E QuinnR Ward
Dec 21, 2004·Critical Reviews in Oncology/hematology·Stephen G ChaneyYibing Wu
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S PopatR S Houlston
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz F KabbinavarSomnath Sarkar
Feb 24, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Katrin LetschertDietrich Keppler
Mar 24, 2006·The British Journal of Surgery·K SöreideJ P A Baak
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro
Mar 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Siân JonesSanford D Markowitz
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Inti ZlobecAlessandro Lugli
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
Apr 14, 2010·BMC Immunology·Vanessa DeschoolmeesterJan B Vermorken
Apr 27, 2010·Nature Cell Biology·Louis VermeulenJan Paul Medema
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Albert de la Chapelle, Heather Hampel
Oct 28, 2010·JAMA : the Journal of the American Medical Association·Wendy De RoockSabine Tejpar
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
May 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian P PollackTodd V Cartee
May 28, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Vanessa DeschoolmeesterMarc Peeters
Oct 20, 2011·Genome Research·Mauro CastellarinRobert A Holt
Oct 20, 2011·Genome Research·Aleksandar D KosticMatthew Meyerson
Feb 7, 2012·International Journal of Cancer. Journal International Du Cancer·Jue-Yu ZhouWen-Li Ma
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Mar 23, 2012·Nature Reviews. Cancer·Karolina Palucka, Jacques Banchereau

❮ Previous
Next ❯

Citations

Apr 12, 2019·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Francis Park-Yun CheungGavin Michael Wright
Sep 13, 2019·Journal of Cellular Biochemistry·Maryam HejaziBehzad Baradaran
Jan 10, 2020·Expert Review of Proteomics·David I CantorSeong Boem Ahn
Oct 24, 2019·Human & Experimental Toxicology·A Palko-ŁabuzK Michalak
Apr 3, 2020·Expert Opinion on Drug Delivery·Xueqing ZhangBo Xiao
Jun 28, 2020·International Journal of Colorectal Disease·Cheng-Ann Winston NgChin Meng Khoo
Feb 23, 2020·Frontiers in Oncology·Águeda Martínez-BarriocanalHiginio Dopeso
May 8, 2020·JCI Insight·Kevin Van der JeughtXiongbin Lu
Jun 17, 2020·Journal of Experimental & Clinical Cancer Research : CR·Roberto DinamiPasquale Zizza
Jul 16, 2020·International Journal of Molecular Sciences·Mateusz KciukRenata Kontek
Sep 26, 2020·International Journal of Molecular Sciences·Mina RaileanuMihaela Bacalum
Aug 22, 2020·Biomarker Research·Nelly N Miteva-MarchevaVili K Stoyanova
Apr 24, 2019·Cancer Cell International·Ian T SaundersShailesh Singh
Mar 25, 2020·International Journal of Molecular Sciences·Elda ChiainoMaria Frosini
Apr 24, 2020·Scientific Reports·Soon-Chan KimJa-Lok Ku
Oct 3, 2020·World Journal of Gastrointestinal Oncology·Amirsaeed Sabeti AghabozorgiEbrahim Eftekhar
May 23, 2019·Molecular and Cellular Biochemistry·Jiangning Li, Xiaofeng Li
Jul 14, 2020·Case Reports in Oncological Medicine·Tetsuro KawagoeKatsuhiko Iwakiri
Aug 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anjugam ParamananthamWon Sup Lee
Sep 16, 2020·Toxins·Bei Cheng, Peisheng Xu
Nov 11, 2020·Cancer Chemotherapy and Pharmacology·Timothy CrookDadasaheb Akolkar

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02997228
NCT02912559
NCT02713373
NCT01988896
NCT02788279
NCT01882946
NCT00072098
NCT02324257
NCT02650713

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.